{
  "pmcid": "12093524",
  "sha256": "d3bf6d316dc6331fe46903499bb14fd9e419a20416f4b8010682ef39d184dbc1",
  "timestamp_utc": "2025-11-09T22:15:01.417783+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.637724196277496,
    "reading_ease": 23.949739142696018,
    "word_count": 197
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Remote Ischemic Preconditioning and Anesthetic-Induced Preconditioning in Rabbit Hearts"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a randomised controlled trial, 24 male New Zealand White rabbits were allocated to four groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "24 male New Zealand White rabbits were allocated to four groups"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The rIPC group underwent four cycles of 5-minute hind limb ischemia and reperfusion. The APC group received 2.5 vol% sevoflurane for 20 minutes, followed by a 20-minute washout."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates their combined effect on myocardial protection."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was myocardial infarction size after 30 minutes of global ischemia and 2 hours of reperfusion, assessed using TTC staining."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "24 male New Zealand White rabbits were allocated to four groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Both rIPC and APC significantly reduced myocardial infarction size by over 50% compared to controls (rIPC: 12.1±1.7%; APC: 13.5±2.1%; control: 31.3±3.0%; P<0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}